Interleukins (ILs)

Interleukins (ILs) are a group of cytokines (secreted proteins and signal molecules) that were first seen to be expressed by white blood cells (leukocytes). The function of the immune system depends in a large part on interleukins, and rare deficiencies of a number of them have been described, all featuring autoimmune diseases or immune deficiency. The majority of interleukins are synthesized by helper CD4 T lymphocytes, as well as through monocytes, macrophages, and endothelial cells. They promote the development and differentiation of T and B lymphocytes, and hematopoietic cells.

Many interleukins are classified into families based on structural similarities, receptor chain usage, and functional properties. Examples include the IL-1 family, IL-2 family, IL-6 family, IL-10 family, IL-12 family, IL-17 family, and others. Each family has unique characteristics and plays specific roles in immune regulation and inflammation.

Product List

TargetCatalog#Product NameReactivityPredicted MW
IL-2PCH90024Recombinant Human IL-2Human15.4 kDa
IL-3PCH90028Recombinant Human IL-3Human15 kDa
IL-4PCH90029Recombinant Human IL-4Human15 kDa
IL-6PCH90030GMP Recombinant Human IL-6Human20.8 kDa
IL-7PCH90031GMP Recombinant Human IL-7Human17.3 kDa
IL-12PCH90020GMP Recombinant Human IL-12Human59 kDa
IL-13PCH90021GMP Recombinant Human IL-13Human12.3 kDa
IL-15PCH90022GMP Recombinant Human IL-15Human12.7 kDa
IL-18PCH90023GMP Recombinant Human IL-18Human18.2 kDa
IL-21PCH90025GMP Recombinant Human IL-21Human15.9 kDa
IL-21(hFc Tag)PCH90055GMP Recombinant Human IL-21(hFc Tag)Human51 kDa
IL-23PCH90026GMP Recombinant Human IL-23Human

55.0 kDa(IL-23singlechain);

36.5 kDa(p40)&18.5 kDa(p19)

OSMPCH90036GMP Recombinant Human OSMHuman22 kDa

Validation Data

GMP Recombinant Human IL-2 (Catalog: PCH90024)

undefined

                             IL-2 SDS-PAGE image

undefinedBioactivity image: ≥1×107 IU/mg. Measured in a cell proliferation assay using CTLL-2 mouse cytotoxic T cells.

GMP Recombinant Human IL-4 (Catalog: PCH90029)

undefined

                             IL-4 SDS-PAGE image

undefined                   Bioactivity image: The ED50 for this effect is ≤ 0.2 ng/mL.

GMP Recombinant Human IL-6 (Catalog: PCH90030)

undefined

                             IL-6 SDS-PAGE image

undefined                 Bioactivity image: The ED50 for this effect is ≤ 0.2 ng/mL.

GMP Recombinant Human IL-7 (Catalog: PCH90031)

undefined

                             IL-7 SDS-PAGE image

undefined                   Bioactivity image: The ED50 for this effect is ≤30ng/ml.

GMP Recombinant Human IL-12 (Catalog: PCH90020)

undefined

                           IL-12 SDS-PAGE image

undefined                   Bioactivity image: The ED50 for this effect is <0.5 ng/mL.

GMP Recombinant Human IL-13 (Catalog: PCH90021)

undefined

                            IL-13 SDS-PAGE image

undefinedBioactivity image: The ED50 for this effect is ≤1.0ng/ml, corresponding to a specific activity of ≥1×106 U/mg.

GMP Recombinant Human IL-15 (Catalog: PCH90022)

undefined

                             IL-15 SDS-PAGE image

undefined                   Bioactivity image: The ED50 for this effect is ≤0.5ng/ml.

GMP Recombinant Human IL-18 (Catalog: PCH90023)

undefined

                           IL-18 SDS-PAGE image

undefined                  Bioactivity image: The ED50 for this effect is 1.5-9 ng/mL.

GMP Recombinant Human IL-21 (Catalog: PCH90025)

undefined

                           IL-21 SDS-PAGE image

undefined                   Bioactivity image: The ED50 for this effect is ≤ 8 ng/mL.

GMP Recombinant Human OSM (Catalog: PCH90036)

undefined

                            OSM SDS-PAGE image

undefined                    Bioactivity image: The ED50 for this effect is ≤ 2 ng/mL.

GMP Recombinant Human IL-3 (Catalog: PCH90028)               GMP Recombinant Human IL-23 (Catalog: PCH90026)

undefined

                             IL-3 SDS-PAGE image

undefined

                             IL-23 SDS-PAGE image

GMP Recombinant Human IL-21(hFc Tag) (Catalog: PCH90055)

undefined

                   IL-21(hFc Tag) SDS-PAGE image


References

1.Evolutionary divergence and functions of the human interleukin (IL) gene family. Brocker C, et al. Hum Genomics. 2010. [PMID: 21106488]

2.Implication of Interleukin Family in Cancer Pathogenesis and Treatment. Gonzalez-Aparicio M, et al. Cancers (Basel). 2021. [PMID: 33804410]

3.The history of fever, leukocytic pyrogen and interleukin-1. Dinarello CA. Temperature (Austin). 2015. [PMID: 27226996]

4.Analytic review: Interleukin-6 in surgery, trauma, and critical care: part I: basic science. Jawa RS, et al. J Intensive Care Med. 2011. [PMID: 21262749]

5.Interleukins as Mediators of the Tumor Cell-Bone Cell Crosstalk during the Initiation of Breast Cancer Bone Metastasis. Haider MT, et al. Int J Mol Sci. 2021. [PMID: 33809315]

6. Interleukins in Platelet Biology: Unraveling the Complex Regulatory Network. Huang M, et al. Pharmaceuticals (Basel). 2024. [PMID: 38256942]

7. Interleukin-17 family members in health and disease. Chung S H, et al. International immunology. 2021. [PMID: 34611705]

8. The immunobiology of the interleukin-12 family: room for discovery. Wojno E D T, et al. Immunity. 2019. [PMID: 30995503]

9. Interleukin-6 family cytokines. Rose-John S. Cold Spring Harbor perspectives in biology. 2018. 

10. Inflammasome-independent regulation of IL-1-family cytokines. Netea M G, et al.  Annual review of immunology. [PMID: 25493334]

11. Structural analysis of cytokines comprising the IL-10 family. Zdanov A. Cytokine & growth factor reviews. 2010. [PMID: 20846897]

12. Interleukin-2 family cytokines: potential for therapeutic immmunoregulation. Dumont F J. Expert Opinion on Therapeutic Patents. 2005. [PMID: 39967341]